HOX Therapeutics is focused on developing novel treatments for cancer. Our lead programme is a dual inhibitor of the androgen receptor and is designed to treat patients insensitive to current drugs for castration resistant prostate cancer. Our second programme targets the Hox-PBX interaction; Hox is switched on in solid and haematological tumours.
View Top Employees from HOX Therapeutics LtdWebsite | http://www.hoxtherapeutics.com/ |
Employees | 5 (4 on RocketReach) |
Founded | 2016 |
Technologies |
JavaScript,
HTML,
Nginx
+1 more
(view full list)
|
Industry | Biotechnology, Science and Engineering, Health Care |
Looking for a particular HOX Therapeutics Ltd employee's phone or email?
Nicholas Adams is the CEO of HOX Therapeutics Ltd.
4 people are employed at HOX Therapeutics Ltd.
HOX Therapeutics Ltd is based in Ashtead, Surrey.